AGER, advanced glycosylation end-product specific receptor, 177
N. diseases: 450; N. variants: 16
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phenotype | Neoplastic Process | 6626 | 169 | 0.100 | None | 1.000 | 24 | 3 | 2002 | 2018 | |||||
|
disease | Neoplastic Process | 3669 | 502 | 0.040 | None | 1.000 | 4 | 3 | 2003 | 2016 | |||||
|
phenotype | Diagnostic Procedure | 67 | 108 | 0.100 | None | 1.000 | 3 | 1 | 2010 | 2012 | |||||
|
phenotype | Disease or Syndrome | 716 | 25 | 0.030 | None | 1.000 | 3 | 2008 | 2017 | ||||||
|
disease | Disease or Syndrome | 297 | 3 | 0.210 | None | 1.000 | 3 | 2011 | 2016 | ||||||
|
disease | Disease or Syndrome | 741 | 81 | 0.030 | None | 0.667 | 3 | 2 | 2018 | 2018 | |||||
|
phenotype | Organ or Tissue Function | 272 | 1169 | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2019 | |||||
|
phenotype | Organ or Tissue Function | 41 | 259 | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2010 | |||||
|
phenotype | Disease or Syndrome | 82 | 18 | 0.020 | None | 1.000 | 2 | 2008 | 2017 | ||||||
|
disease | Disease or Syndrome | 21 | 0.200 | None | 1.000 | 2 | 2013 | 2014 | |||||||
|
disease | Disease or Syndrome | 23 | 1 | 0.020 | None | 1.000 | 2 | 2008 | 2010 | ||||||
|
phenotype | Finding | 41 | 259 | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2010 | |||||
|
disease | Disease or Syndrome | 72 | 0.020 | None | 1.000 | 2 | 2017 | 2018 | |||||||
|
phenotype | Clinical Attribute | 430 | 746 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
disease | Disease or Syndrome | 2 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||||
|
disease | Disease or Syndrome | 17 | 6 | 0.010 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||
|
disease | Disease or Syndrome | 467 | 14 | 0.010 | None | 1.000 | 1 | 2017 | 2017 | ||||||
|
phenotype | Sign or Symptom | 9 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||||
|
disease | Disease or Syndrome | 19 | 0.010 | None | 1.000 | 1 | 2014 | 2014 | |||||||
|
disease | Mental or Behavioral Dysfunction | 11 | 2 | 0.010 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
disease | Neoplastic Process | 48 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||||
|
group | Disease or Syndrome | 4 | 0.010 | None | 1.000 | 1 | 2014 | 2014 | |||||||
|
disease | Mental or Behavioral Dysfunction | 39 | 3 | 0.010 | None | 1.000 | 1 | 2010 | 2010 | ||||||
|
disease | Disease or Syndrome | 49 | 1 | 0.010 | None | 1.000 | 1 | 2010 | 2010 | ||||||
|
phenotype | Pathologic Function | 21 | 0.200 | None | 1.000 | 1 | 2013 | 2013 |